Justin Fortune Creeden, Siddharth N Machiraju, Johansen B Amin, Stephen M Stahl
{"title":"从槟榔到Cobenfy:一种古老的娱乐性药物如何产生了一类新的精神分裂症药物-勘误。","authors":"Justin Fortune Creeden, Siddharth N Machiraju, Johansen B Amin, Stephen M Stahl","doi":"10.1017/S1092852925100539","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10505,"journal":{"name":"CNS Spectrums","volume":"30 1","pages":"e74"},"PeriodicalIF":4.1000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"From Betel Nuts to Cobenfy: How an Ancient Recreational Drug Gave Rise to a New Class of Schizophrenia Medications - ERRATUM.\",\"authors\":\"Justin Fortune Creeden, Siddharth N Machiraju, Johansen B Amin, Stephen M Stahl\",\"doi\":\"10.1017/S1092852925100539\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10505,\"journal\":{\"name\":\"CNS Spectrums\",\"volume\":\"30 1\",\"pages\":\"e74\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS Spectrums\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1017/S1092852925100539\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Spectrums","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S1092852925100539","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
期刊介绍:
CNS Spectrums covers all aspects of the clinical neurosciences, neurotherapeutics, and neuropsychopharmacology, particularly those pertinent to the clinician and clinical investigator. The journal features focused, in-depth reviews, perspectives, and original research articles. New therapeutics of all types in psychiatry, mental health, and neurology are emphasized, especially first in man studies, proof of concept studies, and translational basic neuroscience studies. Subject coverage spans the full spectrum of neuropsychiatry, focusing on those crossing traditional boundaries between neurology and psychiatry.